[Market Watch] National Law Practices Expanding Dedicated Health Insurance Appeal Divisions
#Market #Watch #National #Practices #Expanding #Dedicated #Health #Insurance #Appeal #DivisionsAnya Prince Discusses How Insurance Appeals Can Help a Patient by OncLive
Title: Anya Prince Discusses How Insurance Appeals Can Help a Patient
Channel: OncLive
[Strategic Guide] How To Challenge Defense Medical Experts Who Blame Birth Injuries On "Maternal Infection"
The Corporate Denial Machine Meets Big Law: Why National Practices Are Scaling Up Their Health Insurance Appeal Divisions
The Tipping Point: Why National Law Firms Are Suddenly Pivoting to Health Insurance Appeals
If you had told me fifteen years ago that some of the most prestigious, white-shoe national law practices in the country would be spending millions of dollars to build out massive, dedicated health insurance appeal divisions, I probably would have laughed you out of the room. Back then, health insurance disputes were largely viewed as the annoying stepchildren of the legal world. They were treated as low-margin, administrative headaches, or small-potatoes civil disputes that local solo practitioners handled as a favor to a family friend. If a client came in with a denied claim for an MRI or a disputed out-of-network surgical bill, most big-firm partners would politely pat them on the shoulder, offer a sympathetic sigh, and refer them to a state regulatory hotline. The economics simply did not make sense for a national firm to get involved.
But oh, how the tables have turned. Today, we are witnessing a structural realignment in the legal market that is as fascinating as it is overdue. National law practices are no longer ignoring these disputes; they are actively scaling up specialized divisions to wage war against insurance conglomerates. Why? Because the landscape of healthcare litigation has shifted from sporadic, isolated skirmishes to a systemic, multi-billion-dollar battlefield. The sheer volume of denials has reached a crisis point, driven by corporate policies designed to protect profit margins at the expense of patient care. Law firms have realized that there is a massive, untapped market of high-net-worth individuals, self-funded employer plans, and specialty healthcare providers who are completely fed up with being systematically stiffed by commercial payers.
I remember sitting in a smoke-filled diner across from a retired federal judge about ten years ago, discussing a particularly egregious case where a major insurer had denied coverage for a life-saving pediatric oncology treatment. The judge looked at me and said, "The system is built to make people give up. If you make the paperwork confusing enough, the timeline tight enough, and the phone trees long enough, ninety percent of people will just walk away." That conversation stuck with me because it exposed the dark, open secret of the insurance industry: denial is a business model. But when ninety percent of people walk away, that leaves ten percent who are willing to fight—and that ten percent represents a goldmine for national firms that have the resources, the clinical staff, and the litigation muscle to force insurers to pay up.
This isn't just about helping an individual get their physical therapy sessions covered anymore. This is about challenging systemic, programmatic denials that affect tens of thousands of patients at a time. National law practices are realizing that by consolidating their resources, they can build highly efficient, assembly-line-style legal engines that can go toe-to-toe with the automated denial algorithms used by the likes of UnitedHealth, Cigna, and Aetna. They are investing in sophisticated case-management software, hiring clinical experts, and building out divisions that handle everything from initial administrative appeals to high-stakes federal ERISA litigation. The market has tipped, and the smart money in the legal industry is betting heavily on health insurance appeals.
💡 Insider Note: The Shift in Legal Economics
For decades, the billable hour model made individual insurance appeals unprofitable for major firms. The shift toward alternative fee arrangements (AFAs), contingency-based structures for high-value claims, and statutory fee-shifting provisions under ERISA has completely changed the financial calculus, making this sector highly lucrative for top-tier legal talent.
The Algorithmic Denial Boom and the Death of Human Review
To understand why law firms are scaling up so aggressively, you have to understand the monster they are fighting. We are no longer living in an era where a medical director—a real, living, breathing doctor with a stethoscope around their neck—sits at a desk, reviews your medical records, and makes a thoughtful determination about your care. That era is dead and buried. Instead, we are living in the age of the algorithmic denial. Insurers now routinely use proprietary software programs, such as McKesson’s InterQual or UnitedHealth’s PXDX system, to review claims. These algorithms scan medical codes and issue lightning-fast, automated denials in a fraction of a second, often without a single human being ever laying eyes on the patient's file.
This technological shift has resulted in an absolute explosion of prior authorization denials. Patients who have been on stable, life-saving medication regimens for years are suddenly receiving letters stating that their treatment is no longer deemed a "medical necessity." Providers are spending hundreds of hours submitting mountains of clinical documentation, only to have it rejected by a computer program that has been optimized to find any possible excuse to say "no." It is a cold, calculated numbers game. The insurers know that only a tiny fraction of patients will have the stamina, the knowledge, or the resources to appeal a prior authorization denial. By automating the denial process, they save billions of dollars annually, banking on the fact that most people will simply accept the decision or pay out of pocket.
[Claim Submitted] ──> [Algorithmic Scan (PXDX/InterQual)] ──> [Instant Denial (9.2 seconds)]
│
┌─────────────────────────────┴─────────────────────────────┐
▼ ▼
[90% of Patients Give Up] [10% Appeal with Counsel]
(Insurers Pocket Billions) (Firms Build Administrative Record)
I recently looked at data from a state insurance commissioner’s report that showed one major insurer was denying up to 23% of all in-network claims in a single quarter. Think about that for a second. Nearly one in four claims was being rejected. When you look at those numbers, it becomes glaringly obvious that the system is broken. It is not a matter of occasional administrative errors; it is a deliberate, structural barrier designed to ration care by exhaustion. This algorithmic onslaught has created an unprecedented demand for sophisticated medical billing advocacy and legal intervention.
National law practices are stepping into this vacuum. They are building their own technological counter-measures, using AI and machine learning to analyze denial patterns across different insurers, states, and clinical categories. If an insurer is using an algorithm to deny claims, these law firms are using algorithms to identify the weak points in those denials. They are tracking which peer-to-peer review doctors are rubber-stamping denials without reviewing files, which clinical guidelines are being misapplied, and which internal policies violate state or federal law. It is an arms race of data, and for the first time, the legal industry is starting to level the playing field.
Navigating the ERISA Minefield: The Legal Engine Driving the Expansion
If you want to understand the legal backbone of national health insurance appeal divisions, you must understand ERISA—the Employee Retirement Income Security Act of 1974. ERISA is a massive, incredibly complex federal statute that governs the vast majority of employer-sponsored health insurance plans in the United States. If you get your health insurance through your job (and you don't work for a government entity or a church), your plan is almost certainly governed by ERISA. And let me tell you, ERISA is a absolute minefield for the uninitiated. It is a law that was originally designed to protect employee pensions, but over the decades, it has been twisted into a formidable shield that protects insurance companies from liability.
Under ERISA, the rules of engagement are heavily stacked in favor of the insurer. For starters, ERISA preempts almost all state-law claims. This means you cannot sue your employer-sponsored health plan for bad faith insurance in state court. You cannot ask a jury for punitive damages because an insurer's denial caused you pain, suffering, or financial ruin. In the world of ERISA litigation, there are no juries, there are no punitive damages, and there is rarely any live testimony. If you sue an insurer under ERISA, your case will be decided by a federal judge who will look at one thing, and one thing only: the administrative record.
+-----------------------------------------------------------------------------------------+
| THE ERISA LITIGATION PATHWAY |
+-----------------------------------------------------------------------------------------+
| 1. Internal Appeal (The Crucial Stage: Build the Administrative Record) |
| - Must submit all clinical evidence, expert opinions, and medical billing advocacy. |
| 2. Exhaustion of Administrative Remedies |
| - You cannot file a lawsuit until all internal appeal levels are completed. |
| 3. Federal District Court Filing |
| - No jury trial. No discovery. Judge reviews the paper record only. |
| 4. Standard of Review (Arbitrary & Capricious vs. De Novo) |
| - If the plan has discretionary language, the court deferentially favors the insurer. |
+-----------------------------------------------------------------------------------------+
This is where many inexperienced lawyers fall off the cliff. They think they can handle an ERISA appeal the same way they would handle a standard personal injury or breach of contract case. They assume that if the insurer denies the internal appeal, they can just file a lawsuit and introduce new evidence, call expert witnesses, and conduct depositions during the discovery phase of the federal court case. That is a fatal mistake. In an ERISA case, the administrative record is locked the moment the final internal appeal is denied. If a piece of evidence—a doctor's letter, a clinical study, a billing record—is not in that administrative record before the final denial, the federal judge will never see it.
Because the stakes are so high and the rules are so unforgiving, national law practices are building highly specialized ERISA appeals teams. These aren't general litigators who occasionally dabble in insurance; these are hyper-focused ERISA attorneys who know the federal regulations inside and out. They know how to navigate the strict timelines, how to draft appeals that address the specific "arbitrary and capricious" standard of review that federal judges apply, and how to spot procedural violations by the insurer that can tilt the scales in the patient's favor. They are building divisions designed to win the battle at the administrative level, so they never have to step foot in a federal courtroom—but if they do, they have a bulletproof record ready for review.
⚠️ Pro-Tip: The "Arbitrary and Capricious" Trap
Most ERISA plans contain "discretionary clauses" that grant the insurer the sole authority to interpret plan terms. This triggers an "arbitrary and capricious" standard of review in court, meaning the judge must uphold the denial if it is even remotely reasonable. To beat this, your administrative appeal must prove the insurer had a conflict of interest or ignored clear, objective medical evidence.
Why the Administrative Record is Your Only Shot at Victory
Let's double down on this concept of the administrative record because it is the single most critical element of any health insurance dispute, and it is the primary reason why national firms are investing so heavily in pre-litigation appeal divisions. I often tell young attorneys that writing an appeal letter is not like writing a letter of complaint to a customer service department. It is not about venting your frustration or appealing to the insurer’s sense of humanity. An appeal letter is a legal brief disguised as an administrative document. It is the foundation upon which your entire legal strategy rests.
When a national firm takes on a high-value claim—say, a $250,000 out-of-network claim for an emergency specialized surgery—the first thing they do is request the complete administrative file from the insurer. This file often contains hundreds, if not thousands, of pages of internal notes, clinical guidelines, peer review reports, and claim logs. The firm's legal team will painstakingly dissect this file to find where the insurer's process broke down. Did they fail to consult a physician of the appropriate specialty? Did they miss the federal statutory deadline to respond? Did they rely on outdated clinical guidelines that do not reflect the current standard of care?
Once the weaknesses are identified, the team begins the process of "stuffing the record." This is a highly strategic, deliberate process of importing favorable evidence into the administrative file before the clock runs out. The legal team will gather:
- Detailed, customized letters of medical necessity from the treating physicians that directly address the insurer's specific denial language.
- Peer-reviewed medical literature and clinical trial data proving the efficacy of the disputed treatment.
- Expert reports from independent, board-certified medical specialists who can refute the findings of the insurer's peer-to-peer review doctors.
- Comprehensive medical billing advocacy reports showing that the billed charges are reasonable, customary, and in line with market rates.
[Raw Medical File]
│
▼
[National Law Firm Review] ──> [Identify Insurer's Procedural Violations]
│
├─> Add Custom letters from treating physicians
├─> Add Peer-reviewed clinical studies
├─> Add Independent medical specialist reports
├─> Add Medical billing advocacy / market rate data
▼
[Bulletproof Administrative Record] ──> [Insurers Settle or Court Rules in Patient's Favor]
I remember a case involving a client who had been denied coverage for a specialized proton beam therapy to treat a rare brain tumor. The insurer claimed the treatment was "experimental and investigational." The family was devastated and ready to give up. We took the case, and instead of just writing a generic appeal saying "please cover this," we spent three weeks compiling a 400-page administrative submission. We included clinical guidelines from the American Society for Radiation Oncology, five peer-reviewed studies showing superior outcomes for this specific tumor type, and a searing expert opinion from a world-renowned neuro-oncologist. When the insurer saw the sheer volume and quality of the record we had built, they reversed their denial within forty-eight hours. They knew that if they went to court with that record, they would get absolutely obliterated by a federal judge.
This is why national firms are scaling up. Building a bulletproof administrative record requires massive resources, clinical expertise, and legal sophistication. It is not something that can be done effectively by a stressed-out patient or a general practice lawyer working off the corner of their desk. It requires a dedicated, well-oiled machine that can produce high-quality, scientifically backed, legally precise appeal packages at scale.
Anatomy of a Modern Health Insurance Appeal Division
So, what does one of these modern, national health insurance appeal divisions actually look like? It is a far cry from the traditional law firm setup of partners, associates, and legal assistants. Instead, these divisions are highly interdisciplinary, collaborative hubs that look more like a hybrid of a law firm, a medical clinic, and a forensic accounting agency. They are designed to attack denials from every conceivable angle—legal, clinical, and financial.
At the heart of these divisions is a specialized intake and triage team. Because these firms receive thousands of inquiries a week, they must be incredibly efficient at separating the wheat from the chaff. They use advanced screening protocols to identify high-value claims, systemic denial patterns, and cases with strong legal merit. Once a case is accepted, it is assigned to a dedicated multidisciplinary team consisting of:
- ERISA and Healthcare Litigators: The legal quarterbacks who oversee the strategy, draft the formal appeal briefs, and prepare the case for federal or state court if necessary.
- Nurse Paralegals and Clinical Analysts: Registered nurses (RNs) or nurse practitioners (NPs) who speak the language of medicine. They review medical records, translate complex clinical jargon into clear legal arguments, and interface directly with the patient's treating physicians.
- Medical Billing Advocates and Forensic Coders: Financial experts who specialize in dissecting complex medical bills, identifying coding errors, challenging balance billing practices, and proving that charges meet "usual, customary, and reasonable" (UCR) standards.
- In-House Medical Directors: Board-certified physicians who provide peer-level reviews, draft independent medical opinions, and prepare treating doctors for the dreaded peer-to-peer review calls with insurance company representatives.
💡 Insider Note: The Power of Clinical Staff
The secret weapon of a top-tier appeal division is not the lawyers; it's the clinical staff. A nurse paralegal can spot a misapplied clinical guideline or a missing piece of diagnostic data in five minutes that would take an experienced litigator five hours to find.
This team-based approach allows the firm to mount a comprehensive attack. While the clinical team is busy proving medical necessity, the billing advocates are dissecting the financial codes, and the lawyers are building the legal framework to hold the insurer accountable. It is an incredibly powerful model that completely changes the dynamic of the appeal process. Insurers are used to dealing with isolated, overwhelmed patients; when they find themselves staring down a coordinated, highly professional team of legal and clinical experts, their risk calculation changes dramatically.
The Rise of the In-House Medical Director and Clinical Advocacy Teams
One of the most significant and telling trends in the expansion of national health insurance appeal divisions is the direct hiring of in-house medical directors. Historically, law firms would hire external medical experts on a contract basis to review files and write opinions. This was slow, expensive, and often disconnected from the overall legal strategy. Today, leading national practices are bringing doctors directly onto their payrolls, creating internal clinical advocacy teams that work side-by-side with the legal staff.
This is a brilliant strategic move. When a law firm has an in-house medical director, they gain immediate credibility with both the insurer and the treating physicians. I have seen treating doctors who were completely unresponsive to legal assistants suddenly open up and spend an hour on the phone when they realize they are speaking to a fellow physician who understands the clinical nuances of the patient's condition. The in-house medical director can speak doctor-to-doctor, helping the treating physician articulate their clinical reasoning in a way that aligns perfectly with the legal requirements of the appeal.
[Treating Physician] <───(Doctor-to-Doctor Dialogue)───> [In-House Medical Director]
│
▼
[Translates Clinical Reality
into Legal Arguments]
│
▼
[ERISA Litigator Integrates
into Administrative Record]
Furthermore, these clinical advocacy teams are essential for preparing providers for the peer-to-peer review process. The peer-to-peer review is one of the most insidious tools in the insurer's arsenal. It is a scheduled phone call where an insurance company doctor discusses the case with the treating physician. In theory, it is a collaborative clinical discussion; in practice, it is often a trap. The insurer’s doctor is trained to ask leading, highly technical questions designed to elicit an admission that the treatment is not strictly necessary or could be delayed. Treating physicians, who are already overworked and stressed, often go into these calls unprepared and unwittingly doom the patient's claim.
An in-house clinical team changes this dynamic entirely. They brief the treating physician before the call, giving them a cheat sheet of the key clinical guidelines, the specific plan language, and the common trap questions the insurer's doctor is likely to ask. They ensure that the treating physician goes into that call armed with the data and the confidence needed to defend their treatment plan. In some cases, if allowed by the plan, the firm's in-house medical director can even participate in the call directly, shutting down any bad-faith tactics by the insurer's representative. This level of clinical advocacy is a game-changer, and it is a major reason why national firms with these resources are seeing such high success rates.
Bad Faith Litigation and Out-of-Network Battles: The High-Stakes Revenue Drivers
While ERISA appeals form the steady, bread-and-butter foundation of these divisions, the real high-stakes, high-revenue drivers are bad faith insurance lawsuits and out-of-network reimbursement disputes. These are the cases that keep insurance executives awake at night, and they are the cases that national law practices are actively hunting for.
When a health insurance plan is not governed by ERISA—such as individual policies purchased on the healthcare exchange, government employee plans, or church plans—it falls under state law. And in state court, the kid gloves come off. Under state law, if an insurer unreasonably denies a claim or engages in unfair claims practices, they can be sued for bad faith. This opens the door to compensatory damages for emotional distress, financial ruin, and, most importantly, punitive damages. A single bad faith verdict can cost an insurer tens of millions of dollars, creating an enormous incentive for them to settle claims quickly and fairly when a reputable national firm gets involved.
+-----------------------------------------------------------------------------------------+
| ERISA VS. STATE BAD FAITH |
+-----------------------------------------------------------------------------------------+
| FEATURE | ERISA PLANS (Employer-Sponsored) | NON-ERISA PLANS (State Law) |
+--------------------------+-----------------------------------+----------------------------------+
| Punitive Damages | Strictly Prohibited | Allowed (Can be Millions) |
| Jury Trial | No (Bench Trial Only) | Yes (Highly Sympathetic Juries) |
| Pain & Suffering Damages | No | Yes |
| Discovery Process | None (Administrative Record Only) | Full (Depositions, Internal Emails)|
| Standard of Review | Deferential to Insurer | Neutral / Favorable to Insured |
+-----------------------------------------------------------------------------------------+
I remember a case from a few years ago involving a young woman who was denied coverage for an out-of-network emergency liver transplant. The insurer claimed the hospital was out-of-network and that the patient should have been transferred to an in-network facility three states away, despite the fact that she was actively dying and too unstable to travel. Because this was a state-law plan, we were able to file a bad faith lawsuit and conduct extensive discovery. We uncovered internal emails where claims adjusters joked about the cost of the transplant and actively looked for ways to delay the approval until the patient "was no longer their problem." When those emails were read aloud during a deposition, the insurer's lawyers turned pale. They settled the case for an eight-figure sum the following week. That is the power of state-law bad faith litigation.
In addition to bad faith cases, out-of-network claims represent a massive area of growth. With the passage of the federal No Surprises Act, the rules surrounding balance billing and out-of-network emergency care have become incredibly complex. Hospitals, specialty medical groups, and ambulatory surgical centers are finding themselves in constant, high-value disputes with insurers over what constitutes a "reasonable" reimbursement rate for out-of-network services. National law practices are building dedicated divisions to represent these healthcare providers, using independent medical review (IMR) processes and arbitration to recover millions of dollars in underpaid claims. These are B2B disputes with massive financial scale, making them highly attractive to top-tier national firms.
From Prior Authorization Rejections to Peer-to-Peer Showdowns
To truly appreciate the day-to-day battle of this work, you have to look at the transition from a simple prior authorization denial to the high-stakes peer-to-peer review. It is a process that is fraught with tension, strategy, and clinical drama. Let's look at a hypothetical, yet highly realistic, scenario that plays out thousands of times a day across the country.
Imagine a patient, Sarah, who has a severe, treatment-resistant form of Crohn's disease. Her gastroenterologist, Dr. Chen, prescribes a cutting-edge biologic medication that has shown incredible results in clinical trials. The cost of the medication is $15,000 a month. Sarah's insurer immediately issues a prior authorization denial, claiming that she must first "fail" three older, cheaper medications—a dangerous and painful process known as "step therapy" or "fail first" protocols. Dr. Chen's office, overwhelmed with patients, submits a generic appeal form which is promptly denied by the insurer's automated system.
[Biologic Prescribed ($15k/mo)]
│
▼
[Prior Auth Denial (Step Therapy)]
│
▼
[Generic Appeal Denied by Algorithm] ──> [Enter National Law Firm Appeal Division]
│
▼
[In-House MD Briefs Dr. Chen]
│
▼
[Peer-to-Peer Review Showdown]
│
▼
[Denial Reversed / Drug Approved]
This is where the national firm's appeal division steps in. A nurse paralegal reviews Sarah’s medical records and notes that she has already tried and had severe adverse reactions to two of the cheaper medications, and the third is clinically contraindicated because of her underlying heart condition. The firm's in-house medical director contacts Dr. Chen and schedules a briefing session. They review the specific clinical guidelines and prepare Dr. Chen for the upcoming peer-to-peer review call with the insurer's medical director.
During the actual peer-to-peer call, the insurer's doctor—who, it turns out, is a retired pediatrician who has not treated a patient in fifteen years—attempts to argue that Sarah has not met the criteria for the biologic. But Dr. Chen is ready. Armed with the cheat sheet provided by the law firm, Dr. Chen calmly cites the specific medical records showing the prior adverse reactions, quotes the contraindication guidelines for the third drug, and references a recent study from the New England Journal of Medicine proving the long-term efficacy of the prescribed biologic for Sarah's exact clinical profile. He politely but firmly points out that forcing Sarah to undergo step therapy would constitute medical malpractice and that the insurer would be held fully liable for any resulting bowel perforation or emergency hospitalization.
The insurer's doctor, realizing they are completely outmatched and that every word of the call is being documented for the administrative record, backs down. The denial is reversed, and Sarah gets her medication. This is not a victory of luck; it is a victory of preparation, clinical expertise, and legal pressure. It is a microcosm of the daily warfare that national appeal divisions are waged on behalf of patients and providers nationwide.
The Future of Healthcare Litigation: What This Shift Means for Patients and Providers
As national law practices continue to expand their health insurance appeal divisions, we are going to see a profound, systemic shift in the balance of power between patients, healthcare providers, and insurance conglomerates. For too long, insurers have operated with impunity, secure in the knowledge that the legal system was too slow, too expensive, and too complex for the average person to navigate. But as big law firms bring their massive resources, technological sophistication, and clinical expertise to bear, that calculation is changing.
In the coming years, we can expect to see several key trends emerge:
- Increased Class-Action Litigation: National firms will increasingly use the data gathered from individual appeals to launch massive class-action lawsuits challenging systemic, algorithmic denial practices. We are already seeing the beginnings of this with class actions targeting the use of AI in claims processing.
- Regulatory Crackdowns: As law firms expose the internal, bad-faith practices of insurers through litigation and discovery, state and federal regulators will be forced to step in with stricter rules regarding prior authorizations, step therapy, and algorithmic decision-making.
- Rise of Medical Billing Advocacy: The integration of medical billing advocacy into mainstream legal practice will become the standard. Providers and patients will no longer view billing disputes as purely administrative matters, but as high-stakes legal issues requiring professional representation.
- Consolidation of Specialty Law Firms: We will likely see a wave of consolidation, with large national practices acquiring smaller, boutique healthcare appeal firms to quickly scale up their clinical and legal capabilities.
[Big Law Scales Appeal Divisions] ──> [More High-Value Denials Overturned]
│
┌──────────────────────────────────────────┴──────────────────────────────────────────┐
▼ ▼
[Insurers Forced to Modify AI Algorithms] [Class Actions Explode]
│ │
└──────────────────────────────────────────┬──────────────────────────────────────────┘
▼
[Systemic Shift in Patient Advocacy]
For patients, this shift is a ray of hope in an otherwise bleak and frustrating healthcare landscape. It means that when they are facing a life-altering denial, they no longer have to fight the corporate machine alone. They can partner with a powerful, sophisticated legal ally that has the resources to level the playing field. For healthcare providers, it means they can finally focus on what they do best—treating patients—while leaving the financial and legal warfare to the experts.
We are entering a new era of accountability in healthcare. The corporate denial machine has met its match, and the legal industry is ready for the fight.
Conclusion: A New Era of Accountability in Healthcare Law
When we step back and look at the macro trends, the rapid expansion of dedicated health insurance appeal divisions within national law practices is more than just a smart business move; it is a necessary societal correction. For decades, the American healthcare system has allowed financial gatekeepers to make critical clinical decisions under the guise of "utilization review" and "cost containment." We have allowed algorithms and corporate bottom lines to dictate who gets treatment, when they get it, and how much they have to pay for it.
But the law
[Ethics Watch] Ensuring Claimants Maintain Ultimate Approval Rights Over Final Settlement Tiers[Expert Advice] How Denial Lawyers Prove That Insurance Rejection Language Was Ambiguous